Presnell Sharon Collins 4
4 · ORGANOVO HOLDINGS, INC. · Filed Nov 13, 2018
Insider Transaction Report
Form 4
Presnell Sharon Collins
EVP, Research & Development
Transactions
- Sale
Common Stock
2018-11-08$1.27/sh−40,000$50,800→ 292,193 total
Footnotes (2)
- [F1]The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]This number does not include 2,257,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell beneficially owns or has a right to acquire 2,549,385 shares of common stock.